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Abstract
Brain glycogen metabolism was recently observed in vivo and found to be very slow in the lightly -chloralose anesthetized rat [J.
Neurochem. 73 (1999) 1300]. Based on that slow turnover, the total glycogen content in the awake rat brain and its turnover time were
assessed after administering 13C-labeled glucose for 48 h. Label incorporation into glycogen, glucose, amino acid, and N-acetyl-aspartate
(NAA) resonances was observed. The amount of 13C label incorporated into glycogen was variable and did not correlate with that in
glutamate (r = −0.1, P > 0.86). However, the amount of 13C label incorporated into glycogen was very similar to that in NAA (r = 0.93),
implying similar turnover times between brain glycogen and NAA (∼10 h). Absolute quantification of the total concentration of brain
glycogen in the awake, normoglycemic rat yielded 3.3± 0.8mol/g (n = 6, mean ± S.D.).
© 2003 Elsevier Science Ltd. All rights reserved.
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1. Introduction
Glucose is the main substrate for brain energy metabolism.
However, an endogenous store of carbohydrates, brain
glycogen, can serve as an energy reserve when glucose
supply is limited. The concentrations of brain glycogen can
be influenced by glucose (Goldberg and O’Toole, 1969;
Nelson et al., 1968), anesthetics (Nelson et al., 1968;
Nordstrom and Siesjo, 1978) and neurotransmitters
(Magistretti et al., 1986; Pellerin and Magistretti, 1994).
It has also been suggested that brain glycogen metabolism
may be affected by neuronal activity such as focal physio-
logic stimulation (Swanson, 1992).
To date, brain glycogen concentrations were mainly mea-
sured by invasive methods such as biochemical analysis and
enzymatic analysis. Due to rapid postmortem degradation
of brain glycogen, quantitative determination of glycogen
content in the brain is rather challenging (Cruz and Dienel,
2002; Kong et al., 2002). However, brain glycogen can be
measured using in vivo 13C nuclear magnetic resonance
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(NMR) in conjunction with infusion of 13C-labeled glu-
cose. We recently demonstrated (Choi et al., 1999) that
serial measurements of brain glycogen in vivo over 16 h are
possible from a single animal using specifically designed
three-dimensional localized 13C NMR methods to ensure
that extra-cerebral glycogen does not contaminate the sig-
nal (Choi et al., 2000). In our previous study, we observed
a maximal concentration of [1-13C] brain glycogen of
5.1mol/g during hyperglycemia and that the steady-state
turnover rate was very slow, 0.5mol/(g h), in the lightly
-chloralose anesthetized rat brain in vivo (Choi et al.,
1999).
Considering that anesthetics and brain glucose content
have been reported to affect glycogen metabolism, we be-
came interested in assessing total brain glycogen content in
the awake normoglycemic brain. Therefore, we sought to es-
timate (a) the total concentration of brain glycogen and (b)
the metabolic rate of brain glycogen in the awake normo-
glycemic animal using 13C NMR methods. To achieve these
aims, we employed a novel strategy, namely the comparison
of the amount of 13C label incorporated into glycogen with
that into amino acids, i.e. glutamate and NAA, while admin-
istering 13C-labeled glucose for 2 days. A preliminary ac-
count of part of this work has appeared (Choi and Gruetter,
2001).
0197-0186/03/$ – see front matter © 2003 Elsevier Science Ltd. All rights reserved.
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2. Materials and methods
2.1. Animal preparation
The study was approved by the Institutional Animal Care
and Use Committee (IACUC) and conducted according to
the guidelines for the care and use of laboratory animals
at the University of Minnesota. Male Sprague-Dawley rats
(241±11 g, mean±S.E., n = 6) were fasted overnight with
free access to water prior to the study to minimize the amount
of unlabeled glycogen in the liver. The animals were then
allowed access to a 99%-enriched [1-13C] glucose solution
(5−10%, w/v) ad libitum, which was the only exogenous
carbon source for at least 48 h. After 2 days, animals were
anesthetized using 2% isoflurane (Marsam Pharmaceuticals,
Cherry Hill, NJ) in a 1:1 mixture of nitrous-oxide (N2O) and
oxygen (O2) gases for surgery to insert a catheter into the left
femoral vein for a bolus intravenous infusion of -chloralose
(24 mg/kg body weight). After preparation, which lasted less
than 1 h, animals were immediately placed in the magnet
and the 13C NMR measurements begun.
2.2. NMR methods
All experiments were performed on a 9.4 T, 31-cm
horizontal-bore magnet (Magnex Scientific, UK), interfaced
to a Varian INOVA console (Palo Alto, CA, USA). An
actively shielded gradient coil (Magnex Scientific, Abing-
don, UK) with an 11-cm inner diameter was used and a
home-built quadrature 1H surface RF coil (14-mm diame-
ter) and a linearly polarized three-turn 13C RF coil (12-mm
diameter) were used as a transceiver for 1H NMR and 13C
NMR as described previously (Adriany and Gruetter, 1997).
A 99% 13C-enriched formic acid sphere was located at the
center of the linearly polarized coil as an external refer-
ence and the coil was placed on the animal’s head (Choi
et al., 2000). Automated localized shimming with a fully
adiabatic version of FAST(EST)MAP was used (Gruetter
and Tkac, 2000). The full-width-at-half-maximum of the
in vivo water signal was about 20 Hz in a nominal 510-l
volume. The volume of interest (VOI) was placed in the
brain and a 510-l volume was the typical size of the nom-
inal VOI. Three-dimensional localization based on outer
volume saturation using the SIRENE method (Choi et al.,
2000) combined with adiabatic excitation and WALTZ-16
1H decoupling during the 100-ms acquisition time was
used as in previous studies (Choi et al., 1999, 2000). The
efficiency of localization was verified from the absence of
the natural abundance lipid signal (30.5 ppm) in spectra
optimized for the amino acid region (20−40 ppm) as the
lipid signals are not detectable in the normal brain in vivo.
The localized signals of glycogen and glucose were ac-
quired over 25 min and the spectrometer offset was set to
100 ppm (repetition time, TR = 1 s, 64 scans). The acqui-
sition of localized signals from the amino acid region was
interleaved with spectrometer offset set to 30.5 ppm (TR =
1.5 s, 64 scans) to minimize chemical shift displacement
errors.
2.3. Comparison of turnover rates between glycogen
and amino acids
The standard approach to measure or estimate a metabolic
rate is to measure the temporal changes in the precursor iso-
topic enrichment, such as plasma glucose, and to use this
information as input to the modeling of the measured rate
of labeling of the product P. For the rat studies performed
over 48 h in this study, this was not a feasible approach. In-
stead, we propose to estimate the rates of metabolism rela-
tive to those from another compound with a known turnover
time, based on the following argument: first, the rate of la-
bel incorporation from a precursor (e.g. plasma glucose or
acetyl-CoA) to a metabolic product P is given according to
tracer methodology (e.g. Eq. (1) in Gruetter et al., 1998a,b).
For the present calculation, a metabolic steady state was as-
sumed, i.e. it was assumed that the rate of label incorpora-
tion is dominated by turnover (label cycling in and out of the
metabolite) rather than net concentration changes, as is the
case for the brain amino acids. Brain glycogen metabolism
may also be at a quasi-steady state, because it is unlikely
that brain glycogen concentration accumulates steadily over
the two full day/night cycles measured here. At metabolic
steady state, concentration changes are small and a rapid rise
in isotopic enrichment of the precursor from natural abun-
dance (0.011) to a new value IE0 (assuming IE0  0.011)
results in a slower labeling of the product with a time course
for the isotopic enrichment for metabolite, IEP = 13P(t)/P,
that is given by
13IEP(t) = IE0(1− e−t/τ) (1)
where the time constant τ is the turnover time which is re-
lated to the label half-life τ1/2 = 0.7τ and is given by τ =
P /V. P is the pool size (in mol/g) and V the turnover rate or
metabolic rate (in mol/g min). The amount of label incor-
porated into two distinct metabolites with similar turnover
times will thus change very similarly in time.
Label incorporation into glucose, glutamate and NAA oc-
curs with distinctively different time scales with half-life
τ1/2 on the order of ∼10 min, 1−2 h and ∼14 h, respec-
tively (Choi and Gruetter, 2000; Hyder et al., 1996; Moreno
et al., 2001; Pfeuffer et al., 1999a), according to the rela-
tive metabolic rates and pool sizes. It has been reported that
the turnover of NAA is very slow (Gruetter et al., 1998a,b;
Kunnecke et al., 1993) with some studies reporting rates
on the order of 0.5mol/(g h) based on 13C NMR studies
with 13C-labeled glucose infusion (Choi and Gruetter, 2000;
Moreno et al., 2001).
2.4. Quantification of NMR signals
The 13C NMR signals of brain glycogen (in mol glu-
cosyl units/g wet weight), glucose, glutamate and NAA
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were quantified using the external reference method (Choi
et al., 1999; Gruetter et al., 1998a,b). In brief, in vivo 13C
NMR signals of glycogen, glucose, glutamate and NAA
were quantified by comparison with measurements of phan-
tom solutions (pH = 7.2) containing ∼400 mM glucosyl
units of natural abundance oyster glycogen, 0.9 mM of
99%-enriched [1-13C] d-glucose, 250 mM of glutamate and
250 mM of NAA after correction for the effects of loading
and nuclear Overhauser effect on the NMR signals.
To measure the isotopic enrichment of NAA, the total
NAA concentration, [NAA], was set to 8.5mol/g based
on quantification of [NAA] in 1H NMR spectra obtained
from three separate animals using LCModel (Pfeuffer et al.,
1999b) yielding 8.5±0.1mol/g (mean±S.E.) in excellent
agreement with previous studies (Pfeuffer et al., 1999b). 1H
NMR spectra were acquired with a signal-to-noise ratio of at
least 30:1 in 8 min from a 150l volume in the brain using a
STEAM sequence with 2-ms echo time, 5-s repetition time,
and 20-ms mixing time (Tkac et al., 1999).
The concentration of total brain glycogen was calcu-
lated as follows: based on the excellent correlation of
the label incorporated into glycogen, 13Glyc1, and into
NAA C6, 13NAA6, the isotopic enrichment of glycogen,
IEGlyc = 13Glyc1/[Glyc], was assumed to be proportional
to that of NAA, IENAA = 13NAA6/[NAA]. IENAA was cal-
culated from the quantified 13C NMR signal of 13NAA6 C6,
13NAA6, and the average total NAA concentration, [NAA],
which is known to be stable under normoxic conditions. Be-
cause the breakdown of the hexoses into two trioses in gly-
colysis results in pyruvate C3 labeling from the C1 as well
as the C6 of glucose, the isotopic enrichment of acetyl-CoA
(precursor of 13NAA6) can be at most half of that of glu-
cose (precursor of Glyc1). Therefore, we assumed that the
isotopic enrichment of NAA was half of that of glycogen,
and total brain glycogen was calculated from Eq. (2):
[Glyc] =
13Glyc1
2IENAA
(2)
where [Glyc] denotes absolute concentration of glyco-
gen in the brain and 13Glyc1 denotes the concentration
of 13C-labeled glycogen C1 (mol/g glucosyl units). This
quantification assumed that based on the stable [NAA]
and the slow metabolism of NAA, 0.6mol/(g h) (Choi
and Gruetter, 2000; Moreno et al., 2001), the change of
Fig. 1. Label incorporation into brain glycogen and amino acids following administration of 13C-labeled glucose for 2 days. Label incorporation into
glycogen and glucose C1, as well as several metabolites (N-acetyl-aspartate (NAA), aspartate (Asp), glutamate (Glu), and glutamine (Gln)) was observed
in a 13C NMR spectrum acquired over 25 min from the rat brain after 99%-enriched [1-13C] glucose had been administered for over 48 h ad libitum.
Processing consisted of 10 Hz line-broadening and zero-filling prior to Fourier transformation. The spectrum is shown without baseline correction.
13C-labeled NAA concentration and thus IENAA was negli-
gible during the time of acquisition (<30 min).
3. Results
Following 2 days of ad libitum administration of
13C-labeled glucose (Fig. 1), the 13C NMR spectra of the
brain showed in all animals clearly visible labeling of
glycogen, NAA, glutamate (Glu), glutamine (Gln) and as-
partate (Asp) and, in most cases, glucose (Glc). The degree
of labeling was, however, variable, which implied that the
isotopic enrichment of the precursor glucose varied between
animals and possibly in time as well.
The amount of 13C label incorporated into brain glycogen
is most likely to correlate with the amount of label incor-
porated into that amino acid, which has a label half-life
similar to that of glycogen. Therefore, these widely differ-
ent turnover times of amino acids can serve as a reference
to estimate the turnover rate of brain glycogen in the awake
rat brain by comparing the amount of 13C label in brain
glycogen with that in glutamate and NAA, respectively.
The correlation between the amount of label incorpo-
rated into brain glycogen C1 and the amount of label
incorporated into glutamate C4 following ad libitum ad-
ministration of 13C-labeled glucose was not statistically
significant (r = −0.1, P > 0.86 for correlation, dotted line
in Fig. 2A), indicating that glutamate turnover was faster
than brain glycogen turnover. In contrast, an excellent cor-
relation between the concentrations of 13C-labeled brain
glycogen C1 and 13C-labeled NAA C6 was observed with
r = 0.93, P < 0.01 for correlation (solid line in Fig. 2B).
Therefore, from the observation of a slow rate of 13C label
incorporation into NAA similar to that of brain glycogen
(Choi and Gruetter, 2000), it was assumed that the iso-
topic enrichment of NAA was approximately half that of
brain glycogen after more than 2 days of [1-13C] glucose
administration.
Total concentration of brain glycogen (closed squares in
Fig. 2C) was calculated to be 3.3±0.8mol/g (mean±S.D.,
n = 6) using Eq. (2) based on the estimated isotopic enrich-
ment of NAA and the stable concentration of total NAA. The
glycogen concentration on the order of∼3mol/g falls well
into the range of published concentration values (Table 1).
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Fig. 2. Estimation of brain glycogen turnover times and total brain glyco-
gen content. (A) Comparison of label incorporation into brain glycogen
C1, 13Glyc, and glutamate C4 13Glu4 (). The dotted line indicates the
linear regression to the data (r = −0.1, P > 0.86, n = 6). (B) Compar-
ison between label incorporation into brain glycogen C1 and NAA C6
(). The solid line indicates the result of linear regression (r = 0.93,
P < 0.01, n = 6). (C) Total glycogen concentration was calculated using
Eq. (1) and found to be 3.3± 0.8mol/g (mean ± S.D., n = 6).
4. Discussion
This study demonstrates a novel experimental design, by
measuring label incorporation into brain glycogen after ad-
ministration of 13C-labeled glucose for a period of days
Table 1
Brain glycogen concentration reported in rodents
Method Glycogen (mol/g) Subject
13C NMR 3.3 ± 0.8 Rata
Microwave fixation 6b Ratc
Microwave fixation ∼3b Ratd
Microwave fixation 3–4 Rate
Anthrone method 4.2 Ratf
Liquid N2 2.6–4.4g Rath
Preserved brain tissue slice
using nembutal anesthesia
3.1–4.7g Rath
N/A 3.3 Rati
Liquid N2 1.7–2.8 Mousej
Liquid N2 ∼2.2 Mousek
Liquid N2 2.9 Mousel
a Present study.
b Unit in the papers is given as nmol glucosyl units/mg protein. Unit
conversion is based on protein content in the brain to be 11.7% of the
brain wet weight.
c Garriga and Cusso (1992).
d Swanson (1992).
e Kong et al. (2002).
f Strang and Bachelard (1971).
g Unit in the papers is given as mg/g wet wt, which is converted to
mol glucosyl units/g wet weight.
h Taken from Table 2 in (Prasannan and Subrahmanyam, 1972 and
references therein).
i Clarke and Sokoloff (1999).
j Nelson et al. (1968).
k Lowry et al. (1964).
l Watanabe and Passonneau (1973).
(48 h) and comparing the amount of label incorporated into
glycogen with that incorporated into other amino acids.
From this, a new method, to non-invasively estimate total
concentration of brain glycogen in vivo during chronic in-
gestion of 13C-labeled substrates is proposed.
After 2 days of 13C-labeled glucose administration ad li-
bitum, labeling of glycogen, glucose and amino acids was
observed in all animals. The amount of 13C label incorpo-
ration into metabolites was variable, which can be readily
explained by variability in the feeding cycle and variations
in hepatic glucose production (gluconeogenesis) of each an-
imal resulting in a varying isotopic enrichment of plasma
glucose leading to a variable amount of 13C label incorpo-
ration into glycogen, amino acids and NAA.
In principle, at isotopic steady state (t  τ in Eq. (1)),
a variation of the isotopic enrichment IE0 of the common
precursor between animals will lead to a correlation in the
relative amount of label incorporated into two metabolites,
e.g. 13Glyc1 and 13NAA6 that merely reflects the variability
in IE0 between animals. However, in this case the amount
of label in glutamate is expected to correlate also with that
in glycogen, which was clearly not observed. Thus, it is
highly likely that the variable 13NAA6 reflects changes in the
enrichment of the precursor that occurred in the time period
prior to the NMR measurement. Therefore, the excellent
correlation between the amount of label incorporated into
brain glycogen and into NAA suggests that the turnover
time of brain glycogen in the awake rat is comparable to
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that of NAA, which is on the order of 10–14 h (Choi and
Gruetter, 2000; Moreno et al., 2001) and much slower than
that of glutamate, on the order of 1–2 h (Hyder et al., 1996;
Pfeuffer et al., 1999a,b). From our data, we conclude that
metabolism of brain glycogen in the awake rat brain must be
very slow, which is in excellent agreement with our previous
assessment of a basal brain glycogen turnover rate on the
order of 0.5mol/g/h in the -chloralose anesthetized rat,
with an estimated label turnover time of τ = 7–10 h (Choi
et al., 1999), which is comparable to that of NAA.
A study reported changes in the amount of radioactiv-
ity incorporated into glycogen during short periods of so-
matosensory stimulation in the awake rat (Swanson et al.,
1992). It is important to recognize that our study assesses
turnover on a much longer time scale of the total glyco-
gen moiety and thus this turnover is conceivably smaller,
as this has been shown for the limit dextrin (Watanabe and
Passonneau, 1973). In addition, it is possible that only a part
of glycogen molecules is activated during sensory stimula-
tion that may constitute a fraction of the overall NMR signal
of glycogen. In this context, it was interesting to note that
in one case NAA C6 appeared to be labeled nearly close
to 50% suggesting that the correspondingly high concentra-
tion of 13C-labeled brain glycogen was nearly fully labeled.
This is indicative of close to complete labeling of glyco-
gen over 48 h. On the other hand, if the core of the glyco-
gen molecule is not substantially labeled even over a long
time period such as the 48 h in our study, the total brain
glycogen concentration will be underestimated. In this case,
because the outer-most tier of glycogen contains approxi-
mately 50% of all glucosyl units, the ∼3mol/g of brain
glycogen measured in this study represent half of the to-
tal glycogen present. A putative concentration of 6mol/g
places our measurement into the upper range of concentra-
tions reported (Table 1). A very low rate of turnover for the
inner core of glycogen, however, fully supports the main
conclusion of the paper, namely that turnover of the bulk
brain glycogen pool is very slow in the awake rat. Consid-
ering the slow label turnover time, it is likely that major net
glycogen concentration changes occur on an even slower
time scale, which supports the role of brain glycogen in the
proper recognition of hypoglycemia.
The amount of label incorporated into NAA was used to
estimate the total brain glycogen concentration using Eq. (2).
Our results indicate that the quantification of brain glycogen
in vivo using 13C NMR after prolonged administration of
labeled glucose provides consistent values on the order of
3mol/g in spite of a widely variable 13C label incorpora-
tion into NAA C6, 13NAA6 (Fig. 2C). Total brain glycogen
was 3.3 ± 0.8mol/g, in excellent agreement with the lit-
erature values measured in conscious animals (Clarke and
Sokoloff, 1999; Garriga and Cusso, 1992; Sagar et al., 1987;
Strang and Bachelard, 1971) as shown in Table 1. This cal-
culation was based on two assumptions, namely that the iso-
topic enrichment of the precursor for NAA C6, acetyl-CoA,
was half that of the precursor of glycogen, glucose and that
brain glycogen metabolism was in a quasi-steady state. Di-
lution at the level of pyruvate or acetyl-CoA would lead to
an underestimation of IEGlyc and hence to an overestima-
tion of the brain glycogen concentration. The upper limits of
such a label dilution that occurs in such labeling studies can
be estimated from glutamate, since the isotopic enrichment
of acetyl-CoA is likely to be at least as high as that in glu-
tamate. In the lightly anesthetized rat with metabolic rates
closed to the awake condition, this dilution was reported at
25% (Hyder et al., 1996), which would lead to an underesti-
mation of the glycogen concentration by 25%, but the quan-
tification remains within the range of experimental values
(Table 1). However, in the awake brain, where metabolism
of glucose and glutamate turnover are much faster, this iso-
topic enrichment is expected to be higher, because of the rel-
atively smaller contribution of potential diluting reactions.
The strong labeling of NAA observed in one animal cer-
tainly supports the presence of a high isotopic enrichment
in our study.
The second assumption in the quantification of brain
glycogen concentration was that brain glycogen metabolism
was assumed to be at a quasi-steady state. This was justi-
fied on the basis that over two day/night cycles, a persistent
increase in brain glycogen metabolism is highly unlikely.
Changes in brain glycogen content on the order of 30%
appear possible following sleep deprivation (Kong et al.,
2002). In our study, rats were fasted overnight prior to
administration of the glucose, which has been shown not
to affect brain glycogen concentrations substantially (Kong
et al., 2002). However, if the feeding following fasting leads
to net glycogen synthesis, such an increase in brain glyco-
gen concentration would occur mostly at the beginning of
the 48-h period of 13C-labeled glucose administration. Such
an early synthesis of glycogen thus can only influence the
measurements if it persists for 2 days, which would further
reinforce the main conclusion of this study, namely that
brain glycogen metabolism is slow.
It is interesting to note that in our previous study af-
ter 4 h of [1-13C] glucose infusion, the amount of 13C la-
bel incorporated into glycogen C1 was 5.1mol/g (Choi
et al., 1999), which is substantially more (35%) than the
3.3mol/g of total brain glycogen measured in the present
study (P < 0.02). It is likely that in the previous study, to-
tal brain glycogen was even higher as animals experienced
modest hyperglycemia (13−16 mM plasma glucose), which
likely resulted in hyperinsulinemia. Thus, the concentrations
of glycogen C1 may reflect the combined effect of elevated
plasma glucose and/or insulin to promote net glycogen syn-
thesis in the brain, which is in agreement with studies in cell
cultures (Nelson et al., 1968; Swanson et al., 1989). There-
fore, comparison of the glycogen C1 in this study with that
in our previous study supports our previous assertion that
glucose infusion resulted in net glycogen synthesis (Choi
et al., 1999).
Current sensitivities of MR experiments and the low brain
glycogen content preclude natural abundance detection of
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brain glycogen. Instead, 13C-labeled glucose can be used
to transfer label to the brain glycogen pool, which intro-
duces turnover (substrate cycling in and out of glycogen)
as a potential confounding factor. However, in the present
study, potential confounding effects of label turnover in es-
timating total brain glycogen content were further reduced
by referencing to a metabolite with a similar turnover time,
namely NAA. Therefore, we conclude that brain glycogen
metabolism in the normal conscious brain is as slow as NAA
metabolism with complete turnover of the entire brain glyco-
gen requiring more than a day.
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